BioCryst Pharmaceuticals, Inc. (BCRX)
USD 7.04
(3.23%)
USD 7.04
(3.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -116.33 Million USD | 28.79% |
| 2022 | -143.85 Million USD | 19.33% |
| 2021 | -121.73 Million USD | -7.45% |
| 2020 | -167.56 Million USD | -69.54% |
| 2019 | -96.28 Million USD | -6.04% |
| 2018 | -90.36 Million USD | -63.08% |
| 2017 | -56.51 Million USD | -17.95% |
| 2016 | -48.17 Million USD | -22.89% |
| 2015 | -37.63 Million USD | 14.82% |
| 2014 | -40.01 Million USD | -49.16% |
| 2013 | -25.02 Million USD | 4.02% |
| 2012 | -33.78 Million USD | 30.01% |
| 2011 | -52.28 Million USD | -37.16% |
| 2010 | -31.58 Million USD | -141.93% |
| 2009 | -11.83 Million USD | 46.21% |
| 2008 | -23.1 Million USD | 17.38% |
| 2007 | -27.68 Million USD | 33.03% |
| 2006 | -42.79 Million USD | -75.43% |
| 2005 | -25.23 Million USD | -26.66% |
| 2004 | -20.13 Million USD | -79.1% |
| 2003 | -12.57 Million USD | 22.33% |
| 2002 | -17.45 Million USD | -279.42% |
| 2001 | -3.93 Million USD | 57.04% |
| 2000 | -9.16 Million USD | -4.12% |
| 1999 | -7.6 Million USD | -29.41% |
| 1998 | -5.5 Million USD | 49.25% |
| 1997 | -11.7 Million USD | -88.73% |
| 1996 | -8.2 Million USD | 22.83% |
| 1995 | -8.5 Million USD | -48.39% |
| 1994 | -6.2 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -10.15 Million USD | 73.26% |
| 2024 Q2 | 9.08 Million USD | 189.01% |
| 2024 Q3 | 11.38 Million USD | 28.75% |
| 2023 Q3 | -7.73 Million USD | 54.36% |
| 2023 Q1 | -25.03 Million USD | 42.58% |
| 2023 Q2 | -16.95 Million USD | 32.29% |
| 2023 FY | - USD | 28.79% |
| 2023 Q4 | -42.24 Million USD | -446.04% |
| 2022 FY | - USD | 19.33% |
| 2022 Q1 | -49.9 Million USD | 4.33% |
| 2022 Q2 | -34.11 Million USD | 31.64% |
| 2022 Q3 | -15.68 Million USD | 54.02% |
| 2022 Q4 | -43.6 Million USD | -178.02% |
| 2021 Q4 | -52.16 Million USD | -17.02% |
| 2021 FY | - USD | -7.45% |
| 2021 Q1 | -51.17 Million USD | 1.36% |
| 2021 Q2 | -29.56 Million USD | 42.22% |
| 2021 Q3 | -44.57 Million USD | -50.75% |
| 2020 FY | - USD | -69.54% |
| 2020 Q1 | -34.53 Million USD | -12477.06% |
| 2020 Q2 | -35.75 Million USD | -3.53% |
| 2020 Q3 | -42.86 Million USD | -19.89% |
| 2020 Q4 | -51.87 Million USD | -21.03% |
| 2019 Q4 | 279 Thousand USD | 100.8% |
| 2019 Q3 | -34.69 Million USD | -0.95% |
| 2019 Q1 | -28.73 Million USD | -16.92% |
| 2019 Q2 | -34.37 Million USD | -19.62% |
| 2019 FY | - USD | -6.04% |
| 2018 Q2 | -17.75 Million USD | 17.66% |
| 2018 FY | - USD | -63.08% |
| 2018 Q1 | -21.56 Million USD | -24.06% |
| 2018 Q3 | -27.88 Million USD | -57.01% |
| 2018 Q4 | -24.57 Million USD | 11.86% |
| 2017 Q3 | -13.12 Million USD | 14.3% |
| 2017 FY | - USD | -17.95% |
| 2017 Q1 | -10.57 Million USD | -30.73% |
| 2017 Q4 | -17.38 Million USD | -32.45% |
| 2017 Q2 | -15.31 Million USD | -44.79% |
| 2016 Q1 | -18.6 Million USD | -9.3% |
| 2016 Q4 | -8.09 Million USD | 11.41% |
| 2016 FY | - USD | -22.89% |
| 2016 Q3 | -9.13 Million USD | 23.22% |
| 2016 Q2 | -11.89 Million USD | 36.08% |
| 2015 Q4 | -17.02 Million USD | -31.12% |
| 2015 Q2 | 5.5 Million USD | 138.6% |
| 2015 Q1 | -14.26 Million USD | 5.59% |
| 2015 FY | - USD | 14.82% |
| 2015 Q3 | -12.98 Million USD | -335.79% |
| 2014 FY | - USD | -49.16% |
| 2014 Q4 | -15.11 Million USD | -30.33% |
| 2014 Q3 | -11.59 Million USD | 0.03% |
| 2014 Q2 | -11.6 Million USD | -57.42% |
| 2014 Q1 | -7.36 Million USD | -16.73% |
| 2013 Q1 | -5.28 Million USD | 40.61% |
| 2013 Q3 | -6.9 Million USD | 42.61% |
| 2013 Q4 | -6.31 Million USD | 8.6% |
| 2013 FY | - USD | 4.02% |
| 2013 Q2 | -12.03 Million USD | -127.81% |
| 2012 FY | - USD | 30.01% |
| 2012 Q2 | -9.17 Million USD | -88.44% |
| 2012 Q3 | -7.3 Million USD | 20.38% |
| 2012 Q4 | -8.89 Million USD | -21.73% |
| 2012 Q1 | -4.87 Million USD | 63.37% |
| 2011 Q1 | -9.93 Million USD | -8.7% |
| 2011 Q2 | -13.02 Million USD | -31.14% |
| 2011 Q3 | -12.21 Million USD | 6.19% |
| 2011 Q4 | -13.29 Million USD | -8.84% |
| 2011 FY | - USD | -37.16% |
| 2010 Q4 | -9.13 Million USD | 16.86% |
| 2010 FY | - USD | -141.93% |
| 2010 Q3 | -10.99 Million USD | -10.65% |
| 2010 Q1 | -2.72 Million USD | -117.63% |
| 2010 Q2 | -9.93 Million USD | -263.94% |
| 2009 Q3 | -10.69 Million USD | -22.41% |
| 2009 Q1 | -8.97 Million USD | -187.43% |
| 2009 FY | - USD | 46.21% |
| 2009 Q4 | 15.48 Million USD | 244.73% |
| 2009 Q2 | -8.73 Million USD | 2.65% |
| 2008 FY | - USD | 17.38% |
| 2008 Q4 | 10.26 Million USD | 212.02% |
| 2008 Q3 | -9.16 Million USD | 29.47% |
| 2008 Q2 | -12.99 Million USD | 4.75% |
| 2008 Q1 | -13.64 Million USD | -385.49% |
| 2007 Q3 | -11.58 Million USD | -57.88% |
| 2007 Q2 | -7.33 Million USD | -933.81% |
| 2007 Q1 | -709.8 Thousand USD | 93.25% |
| 2007 FY | - USD | 33.03% |
| 2007 Q4 | -2.81 Million USD | 75.74% |
| 2006 Q2 | -10.79 Million USD | -26.1% |
| 2006 Q1 | -8.56 Million USD | -17.61% |
| 2006 FY | - USD | -75.43% |
| 2006 Q4 | -10.5 Million USD | 35.48% |
| 2006 Q3 | -16.29 Million USD | -50.88% |
| 2005 Q4 | -7.28 Million USD | 5.59% |
| 2005 Q3 | -7.71 Million USD | -34.93% |
| 2005 Q2 | -5.71 Million USD | -1.94% |
| 2005 FY | - USD | -26.66% |
| 2005 Q1 | -5.6 Million USD | 1.54% |
| 2004 Q3 | -5.05 Million USD | -5.05% |
| 2004 Q2 | -4.81 Million USD | 7.74% |
| 2004 Q4 | -5.69 Million USD | -12.58% |
| 2004 FY | - USD | -79.1% |
| 2004 Q1 | -5.21 Million USD | -73.82% |
| 2003 Q3 | -3.15 Million USD | 2.17% |
| 2003 Q4 | -3 Million USD | 4.82% |
| 2003 Q2 | -2.95 Million USD | -29.79% |
| 2003 Q1 | -2.48 Million USD | -2.25% |
| 2003 FY | - USD | 22.33% |
| 2002 FY | - USD | -279.42% |
| 2002 Q4 | -2.42 Million USD | 21.76% |
| 2002 Q3 | -3.1 Million USD | 23.71% |
| 2002 Q2 | -4.9 Million USD | 23.63% |
| 2002 Q1 | -5.32 Million USD | -131.19% |
| 2001 Q3 | 146 Thousand USD | 11.8% |
| 2001 FY | - USD | 57.04% |
| 2001 Q1 | -2.33 Million USD | 54.02% |
| 2001 Q2 | 305 Thousand USD | 113.08% |
| 2001 Q4 | -2.3 Million USD | -775.98% |
| 2000 Q3 | -1.8 Million USD | 14.51% |
| 2000 FY | - USD | -4.12% |
| 2000 Q4 | -5.06 Million USD | -102.55% |
| 2000 Q2 | -2.26 Million USD | -245.37% |
| 2000 Q1 | -2.25 Million USD | 187.57% |
| 1999 Q4 | -2.3 Million USD | 4.17% |
| 1999 FY | - USD | -29.41% |
| 1999 Q3 | -2.49 Million USD | -700.0% |
| 1999 Q2 | -308 Thousand USD | 90.0% |
| 1999 Q1 | -2.4 Million USD | -42.86% |
| 1998 Q1 | -3.1 Million USD | 5.41% |
| 1998 Q4 | -1.7 Million USD | -191.3% |
| 1998 Q3 | 2.5 Million USD | 171.88% |
| 1998 Q2 | -2.9 Million USD | 8.57% |
| 1998 FY | - USD | 49.25% |
| 1997 Q1 | -3.4 Million USD | -50.0% |
| 1997 FY | - USD | -88.73% |
| 1997 Q4 | -3.3 Million USD | -23.33% |
| 1997 Q3 | -2.6 Million USD | -57.89% |
| 1997 Q2 | -2.3 Million USD | 36.67% |
| 1996 Q2 | -1.1 Million USD | 42.11% |
| 1996 Q1 | -1.8 Million USD | 17.39% |
| 1996 FY | - USD | 22.83% |
| 1996 Q4 | -2 Million USD | 13.04% |
| 1996 Q3 | -2.3 Million USD | -109.09% |
| 1995 Q1 | -2.7 Million USD | -50.0% |
| 1995 FY | - USD | -48.39% |
| 1995 Q3 | -2 Million USD | -22.22% |
| 1995 Q4 | -2.1 Million USD | -4.55% |
| 1995 Q2 | -1.6 Million USD | 33.33% |
| 1994 Q1 | -1.3 Million USD | 0.0% |
| 1994 Q3 | -1.5 Million USD | 16.67% |
| 1994 Q4 | -1.8 Million USD | -20.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q2 | -1.8 Million USD | -28.57% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Agenus Inc. | -145.92 Million USD | 20.277% |
| Immix Biopharma, Inc. | -16.13 Million USD | -620.981% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 23.553% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -3.378% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 69.383% |
| MiMedx Group, Inc. | 40.51 Million USD | 387.126% |
| Novavax, Inc. | -487.39 Million USD | 76.131% |
| Seer, Inc. | -97.88 Million USD | -18.849% |
| Acelyrin, Inc. | -381.52 Million USD | 69.508% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -390.141% |
| IO Biotech, Inc. | -91.22 Million USD | -27.521% |
| Ardelyx, Inc. | -55.35 Million USD | -110.165% |
| C4 Therapeutics, Inc. | -122.1 Million USD | 4.724% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -161.799% |
| Fortress Biotech, Inc. | -133.64 Million USD | 12.951% |
| Fortress Biotech, Inc. | -133.64 Million USD | 12.951% |
| Geron Corporation | -174.78 Million USD | 33.44% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 33.777% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -50.414% |
| Incyte Corporation | 919.42 Million USD | 112.653% |
| Innoviva, Inc. | 248.96 Million USD | 146.728% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -1285.6% |
| ChromaDex Corporation | -3.89 Million USD | -2887.545% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 214.36% |
| MEI Pharma, Inc. | 26.38 Million USD | 540.997% |
| NextCure, Inc. | -59.03 Million USD | -97.048% |
| Onconetix, Inc. | -36.7 Million USD | -216.931% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 5305.145% |
| GlycoMimetics, Inc. | -39.12 Million USD | -197.365% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | 10.8% |
| Vaxcyte, Inc. | -464.88 Million USD | 74.976% |
| Precigen, Inc. | -89.22 Million USD | -30.382% |
| Pharming Group N.V. | 9.87 Million USD | 1277.837% |
| ContextLogic Inc. | -324 Million USD | 64.094% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -1589.933% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -48.211% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -585.089% |
| AlloVir, Inc. | -190.14 Million USD | 38.818% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -382.48% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | 7.301% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -902779.264% |
| Summit Therapeutics Inc. | 1 Million USD | 11721.878% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 49.407% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -248.454% |
| Senti Biosciences, Inc. | -61.33 Million USD | -89.668% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 29.673% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -276.44% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -36141.433% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -4127.934% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -102.759% |
| Chimerix, Inc. | -92.97 Million USD | -25.126% |
| PDS Biotechnology Corporation | -40.08 Million USD | -190.221% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -477.087% |
| CRISPR Therapeutics AG | -202.7 Million USD | 42.608% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -97.882% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 26.856% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -411.093% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -25.067% |
| Precision BioSciences, Inc. | -32.04 Million USD | -263.07% |
| Dyadic International, Inc. | -8.22 Million USD | -1313.593% |
| Elevation Oncology, Inc. | -41.46 Million USD | -180.548% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -39877.663% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -1593.87% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 54.951% |
| Aptorum Group Limited | -9.59 Million USD | -1111.95% |
| Bicycle Therapeutics plc | -183.4 Million USD | 36.568% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -1801.972% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -404.532% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -484.234% |
| GT Biopharma, Inc. | 5.97 Million USD | 2045.727% |
| Alkermes plc | 495.04 Million USD | 123.5% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -87.043% |
| Jaguar Health, Inc. | -33.13 Million USD | -251.136% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -258.472% |
| AbCellera Biologics Inc. | -192.15 Million USD | 39.459% |
| PureTech Health plc | -11.62 Million USD | -900.559% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -547.26% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -33.065% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 22091.493% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -55.497% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -382.48% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -77.978% |
| AnaptysBio, Inc. | -143.16 Million USD | 18.74% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -244.87% |
| ESSA Pharma Inc. | -26.45 Million USD | -339.742% |
| Molecular Templates, Inc. | 1.43 Million USD | 8235.315% |
| Scopus BioPharma Inc. | -11.71 Million USD | -893.2% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 78.454% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -207452.051% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -148.25% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -301.668% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -63.797% |
| Structure Therapeutics Inc. | -102.45 Million USD | -13.543% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -104.981% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -3.589% |
| ImmuCell Corporation | -2.5 Million USD | -4545.824% |
| Lantern Pharma Inc. | -15.78 Million USD | -636.918% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -297.618% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -1067.085% |
| Opthea Limited | -200.01 Million USD | 41.838% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 50.177% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 25.993% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 32.453% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 43.716% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 234.008% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -127.133% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -1076.657% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 50.835% |
| Aptose Biosciences Inc. | -52.26 Million USD | -122.574% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -7.974% |
| Soligenix, Inc. | -7.85 Million USD | -1381.437% |
| Century Therapeutics, Inc. | -121.2 Million USD | 4.02% |
| Kura Oncology, Inc. | -164.95 Million USD | 29.475% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -45.241% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -1053.43% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -12046.837% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -2599.814% |
| Autolus Therapeutics plc | -156.77 Million USD | 25.793% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -37.419% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -68.599% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -483.601% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 38.536% |
| GRI Bio, Inc. | -10.89 Million USD | -967.489% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -2476.225% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | 5.037% |
| IGM Biosciences, Inc. | -253.35 Million USD | 54.083% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -12.085% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -205.075% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -658.827% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -638.952% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -104.653% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -8.62% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 56.265% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 40.015% |
| Verastem, Inc. | -83.16 Million USD | -39.883% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -130.038% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 26.476% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -1.969% |
| Histogen Inc. | -10.5 Million USD | -1007.636% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -714.688% |
| Surrozen, Inc. | -41.13 Million USD | -182.84% |
| Organovo Holdings, Inc. | -14.8 Million USD | -685.729% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 3627633.52% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -98.141% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -126.8% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -440.113% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -1295.238% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 29.947% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -136.173% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -381.399% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -672.731% |
| Apollomics, Inc. | -171.74 Million USD | 32.264% |
| Amarin Corporation plc | -50.9 Million USD | -128.549% |
| Mesoblast Limited | -61.33 Million USD | -89.684% |
| Turnstone Biologics Corp. | -56.23 Million USD | -106.877% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | 18.761% |
| Synaptogenix, Inc. | -8.3 Million USD | -1300.36% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -658.426% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -84.521% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2327.963% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 27215.251% |
| Exelixis, Inc. | 196.6 Million USD | 159.173% |
| Better Therapeutics, Inc. | -38.26 Million USD | -204.048% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | 17.732% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 76.508% |
| NLS Pharmaceutics AG | -11.79 Million USD | -886.253% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 47158.038% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -294.276% |
| Gritstone bio, Inc. | -126.86 Million USD | 8.299% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -79.018% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -2808.414% |
| Avid Bioservices, Inc. | -11.48 Million USD | -913.283% |
| Insmed Incorporated | -654.73 Million USD | 82.232% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -5071.09% |
| MediWound Ltd. | -4.89 Million USD | -2277.58% |
| OmniAb, Inc. | -49.73 Million USD | -133.929% |
| Alector, Inc. | -142.89 Million USD | 18.585% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -36.169% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -123.086% |
| Zai Lab Limited | -366.57 Million USD | 68.264% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 59.972% |
| Aura Biosciences, Inc. | -83.69 Million USD | -38.997% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 48.353% |
| Immunic, Inc. | -99.11 Million USD | -17.377% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | 11.647% |
| Veracyte, Inc. | -49.4 Million USD | -135.453% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -1546.888% |
| FibroGen, Inc. | -261.4 Million USD | 55.496% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -944.206% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -1561.613% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -521.552% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 108.026% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -357.615% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 391.64% |
| TG Therapeutics, Inc. | 26.1 Million USD | 545.728% |
| Galecto, Inc. | -37.51 Million USD | -210.07% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -204.025% |
| Fortrea Holdings Inc. | 167.3 Million USD | 169.537% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | 13.364% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -310.918% |
| XBiotech Inc. | -35.76 Million USD | -225.267% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -79.018% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -78.291% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -11.373% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -353.159% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -184.667% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 77.474% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -107.663% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -424.751% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 50.509% |
| NexImmune, Inc. | -28.16 Million USD | -313.011% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -2005.402% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -886.536% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 102.5% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -358.156% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | 7.558% |
| Ainos, Inc. | -8.77 Million USD | -1226.042% |
| Pluri Inc. | -20.22 Million USD | -475.204% |
| Prothena Corporation plc | -190.1 Million USD | 38.806% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | 9.254% |
| Celularity Inc. | -183.94 Million USD | 36.756% |
| Rallybio Corporation | -72.37 Million USD | -60.744% |
| Cue Biopharma, Inc. | -46.05 Million USD | -152.617% |
| MeiraGTx Holdings plc | -57.05 Million USD | -103.91% |
| Omeros Corporation | -163.61 Million USD | 28.895% |
| Humacyte, Inc. | -96.45 Million USD | -20.607% |
| Immunocore Holdings plc | -59.64 Million USD | -95.033% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -500.532% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -377.468% |
| Blueprint Medicines Corporation | -474.61 Million USD | 75.488% |
| CalciMedica, Inc. | -34.18 Million USD | -240.27% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -58.854% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 30.938% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 53.907% |
| Pulmatrix, Inc. | -12.64 Million USD | -819.935% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -252.894% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -31.501% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 77.023% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -14.938% |
| Cytokinetics, Incorporated | -456.68 Million USD | 74.526% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -248.59% |
| Nutriband Inc. | -5.12 Million USD | -2171.38% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -168.846% |
| Vor Biopharma Inc. | -114.37 Million USD | -1.717% |
| Roivant Sciences Ltd. | -996.51 Million USD | 88.326% |
| Evogene Ltd. | -23.2 Million USD | -401.358% |
| ProKidney Corp. | -147.66 Million USD | 21.219% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -80.267% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -75861.972% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 79.427% |
| CorMedix Inc. | -48.88 Million USD | -137.967% |
| BioLineRx Ltd. | -57.06 Million USD | -103.878% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -4.095% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -57491.584% |
| Atai Life Sciences N.V. | -36.31 Million USD | -220.385% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -46.302% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -43.071% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 57.774% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -278.448% |
| MediciNova, Inc. | -9.87 Million USD | -1077.483% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | 7.627% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -7502.596% |
| GeoVax Labs, Inc. | -26.66 Million USD | -336.222% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 48.293% |
| Biomea Fusion, Inc. | -124.62 Million USD | 6.648% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 64.783% |
| Mereo BioPharma Group plc | -26.05 Million USD | -346.481% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 38.88% |
| Absci Corporation | -95.45 Million USD | -21.872% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -287.46% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -8.605% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 50.173% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -409.013% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 44.026% |
| Allakos Inc. | -189.91 Million USD | 38.744% |
| Imunon, Inc. | -19.87 Million USD | -485.237% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -7.229% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 207.395% |
| BioAtla, Inc. | -122.24 Million USD | 4.831% |
| NLS Pharmaceutics AG | -11.79 Million USD | -886.253% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -638.119% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 61.26% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -180.684% |
| XOMA Corporation | -39.36 Million USD | -195.552% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -17.209% |
| Cara Therapeutics, Inc. | -117.65 Million USD | 1.118% |
| aTyr Pharma, Inc. | -52.17 Million USD | -122.958% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -38.8% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 21.729% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 50.404% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -752.084% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -1346.539% |
| Akari Therapeutics, Plc | -16.8 Million USD | -592.388% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 61748.808% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 125.741% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -1720.971% |
| UroGen Pharma Ltd. | -63.83 Million USD | -82.255% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -71.295% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -1501.746% |
| Orgenesis Inc. | -60.71 Million USD | -91.599% |
| Entera Bio Ltd. | -8.8 Million USD | -1221.388% |
| GH Research PLC | -41.15 Million USD | -182.689% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -355.876% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -41.47% |
| Xencor, Inc. | -125.87 Million USD | 7.578% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -8055.018% |
| Replimune Group, Inc. | -230.19 Million USD | 49.463% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -477.127% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -963.197% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -1720.971% |
| Portage Biotech Inc. | -18.19 Million USD | -539.238% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -7502.596% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -11.236% |
| OncoCyte Corporation | -23.12 Million USD | -403.114% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -929.48% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -915.42% |
| Purple Biotech Ltd. | -22.22 Million USD | -423.442% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -1714.899% |
| scPharmaceuticals Inc. | -46.06 Million USD | -152.567% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -553.212% |
| HilleVax, Inc. | -132.46 Million USD | 12.177% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -994.094% |
| Tharimmune, Inc. | -9.3 Million USD | -1150.566% |
| Genprex, Inc. | -31.06 Million USD | -274.542% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 37.963% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -271.037% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -15127.094% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 77192.059% |
| OKYO Pharma Limited | -15.74 Thousand USD | -738728.658% |
| Savara Inc. | -59.13 Million USD | -96.734% |
| Curis, Inc. | -45.13 Million USD | -157.726% |
| Daré Bioscience, Inc. | -30.7 Million USD | -278.923% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -665.808% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -1523.657% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -335.157% |
| BeiGene, Ltd. | -1.12 Billion USD | 89.656% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -613.659% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 72.982% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -28.775% |
| Erasca, Inc. | -121.31 Million USD | 4.101% |
| bluebird bio, Inc. | -167.16 Million USD | 30.405% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -2485.937% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 137.493% |
| DBV Technologies S.A. | -85.98 Million USD | -35.302% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -2485.937% |
| Moderna, Inc. | -3.28 Billion USD | 96.456% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -173.029% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -1959.756% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -94.371% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 64.341% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | 15.139% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -145.609% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | 16.326% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 43.488% |
| MacroGenics, Inc. | 2.01 Million USD | 5867.724% |
| RenovoRx, Inc. | -11.39 Million USD | -921.378% |
| Adicet Bio, Inc. | -136.53 Million USD | 14.795% |
| Prime Medicine, Inc. | -193.75 Million USD | 39.959% |
| Aditxt, Inc. | -25.45 Million USD | -356.969% |
| Adagene Inc. | -14.95 Million USD | -678.12% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1491.429% |
| Quantum-Si incorporated | -91.8 Million USD | -26.721% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 116.33% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 191.997% |
| SciSparc Ltd. | -5.28 Million USD | -2102.48% |
| Vericel Corporation | 2.86 Million USD | 4161.976% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -122090.362% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -436.318% |
| Generation Bio Co. | -133.3 Million USD | 12.727% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -40.112% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -35.237% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 48.849% |
| Invivyd, Inc. | -196.61 Million USD | 40.831% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 68.907% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -1154.313% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 528.427% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1031.113% |
| 2seventy bio, Inc. | -206.41 Million USD | 43.641% |
| ADMA Biologics, Inc. | 5.12 Million USD | 2372.168% |
| Clene Inc. | -43.24 Million USD | -169.039% |
| Capricor Therapeutics, Inc. | -23 Million USD | -405.607% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -139.98% |
| GeoVax Labs, Inc. | -26.66 Million USD | -336.222% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 61.165% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -216.736% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 593.51% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 2469.225% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -258.152% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 26.558% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 83.0% |
| Evaxion Biotech A/S | -21.4 Million USD | -443.545% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -75.164% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 46.554% |
| Trevena, Inc. | -35.28 Million USD | -229.673% |
| Surrozen, Inc. | -41.13 Million USD | -182.84% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -46.164% |
| Cingulate Inc. | -22.95 Million USD | -406.861% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -1459.241% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -212.032% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -1314.172% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -13.757% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -71.517% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -99.299% |
| Clearmind Medicine Inc. | -8.71 Million USD | -1235.547% |
| Kronos Bio, Inc. | -121.83 Million USD | 4.51% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -56.486% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -4665.066% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -15.381% |
| Statera Biopharma, Inc. | 38.93 Million USD | 398.793% |
| ImmunityBio, Inc. | -436.18 Million USD | 73.329% |
| Korro Bio, Inc. | -80.9 Million USD | -43.794% |
| Kineta, Inc. | -15.71 Million USD | -640.327% |
| BioVie Inc. | -31.95 Million USD | -264.113% |
| Codexis, Inc. | -49.28 Million USD | -136.055% |
| Celularity Inc. | -183.94 Million USD | 36.756% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 47.481% |
| Celcuity Inc. | -58.3 Million USD | -99.511% |
| Virax Biolabs Group Limited | -6.6 Million USD | -1660.213% |
| Cibus, Inc. | -314.58 Million USD | 63.02% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| IN8bio, Inc. | -28.5 Million USD | -308.136% |
| Kodiak Sciences Inc. | -259.02 Million USD | 55.087% |
| Annexon, Inc. | -141.57 Million USD | 17.828% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -3.318% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -81.218% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -316.151% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 49.422% |
| Eyenovia, Inc. | -24.1 Million USD | -382.597% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 359.769% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -35805.864% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -57.627% |
| Arcellx, Inc. | -64.14 Million USD | -81.363% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -158.442% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | 5.783% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -276.708% |
| Moolec Science SA | -52.07 Million USD | -123.397% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -125.429% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -187.837% |
| Royalty Pharma plc | 1.88 Billion USD | 106.164% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | 2.724% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1147.66% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -460.901% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 29.952% |
| Humacyte, Inc. | -96.45 Million USD | -20.607% |
| 89bio, Inc. | -134.46 Million USD | 13.482% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -47.493% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 2971.051% |
| Genelux Corporation | -24.16 Million USD | -381.419% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -244.186% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 28.831% |
| Notable Labs, Ltd. | -14.4 Million USD | -707.882% |
| Liquidia Corporation | -70.05 Million USD | -66.072% |
| Mustang Bio, Inc. | -48.06 Million USD | -142.047% |
| Immunovant, Inc. | -269.97 Million USD | 56.909% |
| Quantum-Si incorporated | -91.8 Million USD | -26.721% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -63.884% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -502.522% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -14.041% |
| Acasti Pharma Inc. | -11.3 Million USD | -929.422% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -422.778% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -658.827% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 44.737% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -2624.254% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -632.588% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -304.278% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -214.164% |
| PepGen Inc. | -83.58 Million USD | -39.187% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -294.302% |
| United Therapeutics Corporation | 1.38 Billion USD | 108.389% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -408.08% |
| Solid Biosciences Inc. | -93.43 Million USD | -24.51% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -2338.002% |
| Immuneering Corporation | -58.06 Million USD | -100.368% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 3627633.52% |
| Silo Pharma, Inc. | -3.62 Million USD | -3108.167% |
| Belite Bio, Inc | -31.52 Million USD | -268.978% |
| XOMA Corporation | -39.36 Million USD | -195.552% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -72.484% |
| Bionomics Limited | -9.83 Million USD | -1082.627% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -38.519% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -236.17% |
| uniQure N.V. | -253.1 Million USD | 54.036% |
| Cassava Sciences, Inc. | -95.68 Million USD | -21.579% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1491.429% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 10.169% |
| Forte Biosciences, Inc. | -32.47 Million USD | -258.207% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -1345.07% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -312.258% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -35805.864% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -944.206% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -631.621% |
| Altimmune, Inc. | -87.93 Million USD | -32.297% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -26.343% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -236.17% |
| Compugen Ltd. | -12.51 Million USD | -829.49% |
| Peak Bio, Inc. | -1356.23 USD | -8577722.346% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -139.382% |
| Benitec Biopharma Inc. | -22.49 Million USD | -417.274% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 51.988% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -307.578% |
| Zura Bio Limited | -60.56 Million USD | -92.089% |
| PolyPid Ltd. | -20.26 Million USD | -474.125% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -645.116% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -307.578% |
| Instil Bio, Inc. | -146.12 Million USD | 20.385% |
| argenx SE | -216.02 Million USD | 46.147% |
| Immunome, Inc. | -28.27 Million USD | -311.499% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -140.0% |
| Verona Pharma plc | -52.46 Million USD | -121.727% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -22.753% |
| Shattuck Labs, Inc. | -87.61 Million USD | -32.78% |
| CervoMed Inc. | -2.17 Million USD | -5256.434% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | 4.834% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -816.529% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -141.489% |
| Moolec Science SA | -52.07 Million USD | -123.397% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -578.735% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | 10.78% |
| Design Therapeutics, Inc. | -66.32 Million USD | -75.401% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -43.647% |
| NeurAxis, Inc. | -6.66 Million USD | -1645.594% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -208.172% |
| Lumos Pharma, Inc. | -36.57 Million USD | -218.116% |
| Achilles Therapeutics plc | -70.44 Million USD | -65.15% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -22.753% |
| 180 Life Sciences Corp. | -22.13 Million USD | -425.593% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 2095.712% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -4665.066% |
| Nutriband Inc. | -5.12 Million USD | -2171.38% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -6.002% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -109.87% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -130.138% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -78.217% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -114.997% |
| Palisade Bio, Inc. | -12.28 Million USD | -847.276% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -156.38% |
| Beam Therapeutics Inc. | -156.47 Million USD | 25.652% |
| Neurogene Inc. | -52.28 Million USD | -122.497% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | 14.767% |
| AEON Biopharma, Inc. | -48.36 Million USD | -140.555% |
| Sesen Bio, Inc. | -50.84 Million USD | -128.826% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -41.99% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -841.982% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 72.783% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -10.588% |
| Athira Pharma, Inc. | -116.7 Million USD | 0.315% |
| Vaccinex, Inc. | -19.74 Million USD | -489.098% |
| HCW Biologics Inc. | -23.57 Million USD | -393.446% |
| XOMA Corporation | -39.36 Million USD | -195.552% |
| Nektar Therapeutics | -243.1 Million USD | 52.147% |
| Arvinas, Inc. | -394.8 Million USD | 70.533% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 61748.808% |
| Merus N.V. | -149.2 Million USD | 22.031% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -24.436% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -272.153% |
| Rezolute, Inc. | -68.42 Million USD | -70.023% |
| Clene Inc. | -43.24 Million USD | -169.039% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -654.335% |
| BeyondSpring Inc. | -21.54 Million USD | -440.088% |
| Synlogic, Inc. | -55.16 Million USD | -110.901% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -862.799% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -993.169% |
| Peak Bio, Inc. | -1356.23 USD | -8577722.346% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -258.34% |
| Krystal Biotech, Inc. | 17.9 Million USD | 749.771% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | 1.763% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 65.919% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -2425.49% |
| MannKind Corporation | 15.12 Million USD | 868.954% |
| Ikena Oncology, Inc. | -74.39 Million USD | -56.371% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -823.807% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 672.318% |
| Gossamer Bio, Inc. | -172.15 Million USD | 32.423% |
| CohBar, Inc. | -12.06 Million USD | -864.175% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -356.055% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -287.46% |
| Legend Biotech Corporation | -477.87 Million USD | 75.656% |
| Mural Oncology plc | -192.72 Million USD | 39.635% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -2.0% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -620.552% |
| Disc Medicine, Inc. | -91.02 Million USD | -27.806% |
| Champions Oncology, Inc. | -5.05 Million USD | -2201.84% |
| REGENXBIO Inc. | -239.46 Million USD | 51.419% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -985.398% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -108.65% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -200.078% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -3.128% |
| Vaxart, Inc. | -74.72 Million USD | -55.688% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -230.419% |
| Cellectis S.A. | -98.09 Million USD | -18.594% |
| Longeveron Inc. | -20.06 Million USD | -479.935% |
| Repare Therapeutics Inc. | -114.27 Million USD | -1.804% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 73.512% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -55.503% |
| Revolution Medicines, Inc. | -430.58 Million USD | 72.982% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -1749.817% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -277.846% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -55.966% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 2472.731% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -960.967% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 102.526% |
| Denali Therapeutics Inc. | -179.97 Million USD | 35.36% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -122090.362% |
| Veru Inc. | -89.97 Million USD | -29.296% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -332.826% |
| Cingulate Inc. | -22.95 Million USD | -406.861% |
| Passage Bio, Inc. | -98.34 Million USD | -18.298% |
| Context Therapeutics Inc. | -25.06 Million USD | -364.215% |
| Exicure, Inc. | -15.53 Million USD | -648.665% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 43.544% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -214.623% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -1851.08% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 30.944% |
| Nuvalent, Inc. | -149.49 Million USD | 22.18% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -1330.51% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -35.44% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -285.496% |
| OmniAb, Inc. | -49.73 Million USD | -133.929% |
| Anew Medical, Inc. | -1.3 Million USD | -8843.068% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -840.917% |
| Lipocine Inc. | -16.32 Million USD | -612.721% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -74.494% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -56.568% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -205.075% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -198.188% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -424.433% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 78.657% |
| Ocugen, Inc. | -64.82 Million USD | -79.455% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -25.672% |
| Q32 Bio Inc. | -86.5 Million USD | -34.488% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -587.275% |
| Alumis Inc. Common Stock | -156.89 Million USD | 25.849% |
| Equillium, Inc. | -12.13 Million USD | -858.436% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -98.958% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -1371.971% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -516.803% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -149.154% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -9.394% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -550.403% |
| Dominari Holdings Inc. | -22.44 Million USD | -418.427% |
| Edesa Biotech, Inc. | -8.19 Million USD | -1320.427% |
| vTv Therapeutics Inc. | -25.41 Million USD | -357.796% |
| Bio-Techne Corporation | 326.66 Million USD | 135.613% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 69.772% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 153.762% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | 11.268% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -210.799% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 23.008% |
| Nkarta, Inc. | -120.48 Million USD | 3.441% |
| BioCardia, Inc. | -11.56 Million USD | -906.358% |
| Iterum Therapeutics plc | -34.58 Million USD | -236.423% |